國立虎尾科技大學 |

Strategies for Compliance with Government Regulation in a Pharmaceutical Company.

紀錄類型:	書目-語言資料,手稿 : Monograph/item
正題名/作者:	Strategies for Compliance with Government Regulation in a Pharmaceutical Company./
作者:	Jagun, Charles.
面頁冊數:	1 online resource (173 pages)
附註:	Source: Dissertation Abstracts International, Volume: 79-11(E), Section: A.
Contained By:	Dissertation Abstracts International79-11A(E).
標題:	Management. -
電子資源:	click for full text (PQDT)
ISBN:	9780438089075

Strategies for Compliance with Government Regulation in a Pharmaceutical Company.
Jagun, Charles.

Strategies for Compliance with Government Regulation in a Pharmaceutical Company. - 1 online resource (173 pages)

Source: Dissertation Abstracts International, Volume: 79-11(E), Section: A.

Thesis (D.B.A.)--Walden University, 2018.

Includes bibliographical references

Pharmaceutical companies accrued fines of over $30 billion within 25 years because of noncompliance with regulations. Noncompliance with regulations results in fines and an adverse impact on company profitability. Some pharmaceutical company managers lack effective strategies to ensure overall company compliance with regulation. Based on complexity leadership theory, the purpose of this single case study was to explore strategies pharmaceutical company managers used to ensure compliance with regulatory requirements in Nigeria. The target population was functional managers purposely selected because they had successfully implemented strategies for compliance with the regulatory requirements in Nigeria. Data were collected through face-to-face and telephone interviews with 4 company managers and from company records, regulatory documents, and websites. Analysis of data involved using computer-assisted qualitative data analysis tools and content analysis to code and identify patterns and themes. Findings revealed 3 prominent themes: establishment of regulatory affairs unit and engaged leadership; hiring of qualified of employees, training, and continuous learning; and strategies to navigate through barriers to enhance regulatory compliance. The implications for positive social change lie in the availability of affordable pharmaceutical products with implications for the overall health of communities. Compliance with regulatory requirements helps to ensure that pharmaceutical companies develop high quality and safe products, which are critical in healthcare leading to the prevention and cure of diseases, which will ultimately improve and save people's lives.

Electronic reproduction.
Ann Arbor, Mich. :
ProQuest,
2018

Mode of access: World Wide Web

ISBN: 9780438089075Subjects--Topical Terms:

558618
Management.
Index Terms--Genre/Form:

554714
Electronic books.

Strategies for Compliance with Government Regulation in a Pharmaceutical Company.
LDR:02935ntm a2200349Ki 4500 001 917909
005 20181022132250.5
006 m o u
007 cr mn||||a|a||
008 190606s2018 xx obm 000 0 eng d
020 $a 9780438089075
035 $a (MiAaPQ)AAI10830730
035 $a (MiAaPQ)waldenu:20932
035 $a AAI10830730
040 $a MiAaPQ $b eng $c MiAaPQ $d NTU
100 1 $a Jagun, Charles. $3 1192103
245 1 0 $a Strategies for Compliance with Government Regulation in a Pharmaceutical Company.
264 0 $c 2018
300 $a 1 online resource (173 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertation Abstracts International, Volume: 79-11(E), Section: A.
500 $a Adviser: Gergana Velkova.
502 $a Thesis (D.B.A.)--Walden University, 2018.
504 $a Includes bibliographical references
520 $a Pharmaceutical companies accrued fines of over $30 billion within 25 years because of noncompliance with regulations. Noncompliance with regulations results in fines and an adverse impact on company profitability. Some pharmaceutical company managers lack effective strategies to ensure overall company compliance with regulation. Based on complexity leadership theory, the purpose of this single case study was to explore strategies pharmaceutical company managers used to ensure compliance with regulatory requirements in Nigeria. The target population was functional managers purposely selected because they had successfully implemented strategies for compliance with the regulatory requirements in Nigeria. Data were collected through face-to-face and telephone interviews with 4 company managers and from company records, regulatory documents, and websites. Analysis of data involved using computer-assisted qualitative data analysis tools and content analysis to code and identify patterns and themes. Findings revealed 3 prominent themes: establishment of regulatory affairs unit and engaged leadership; hiring of qualified of employees, training, and continuous learning; and strategies to navigate through barriers to enhance regulatory compliance. The implications for positive social change lie in the availability of affordable pharmaceutical products with implications for the overall health of communities. Compliance with regulatory requirements helps to ensure that pharmaceutical companies develop high quality and safe products, which are critical in healthcare leading to the prevention and cure of diseases, which will ultimately improve and save people's lives.
533 $a Electronic reproduction. $b Ann Arbor, Mich. : $c ProQuest, $d 2018
538 $a Mode of access: World Wide Web
650 4 $a Management. $3 558618
650 4 $a Entrepreneurship. $3 559908
650 4 $a Pharmaceutical sciences. $3 1180569
655 7 $a Electronic books. $2 local $3 554714
690 $a 0454
690 $a 0429
690 $a 0572
710 2 $a ProQuest Information and Learning Co. $3 1178819
710 2 $a Walden University. $b Business Administration. $3 1148537
773 0 $t Dissertation Abstracts International $g 79-11A(E).
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10830730 $z click for full text (PQDT)